http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102872050-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcc35f152994b9dd00422a05c7e7572f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40d5dae95e0eef5cc7e988275d603f27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc570b07d4063c42e09dcaa0f330894c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ed7b2f60646f61b214ffebb865618a6 |
| publicationDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102872050-B |
| titleOfInvention | Application of gypensapogenin A to Alzheimer disease treatment drugs |
| abstract | The invention discloses new application of gypensapogenin A which has acetylcholinesterase suppression activity and nerve cell protection function and is used as a multi-target compound for the preparation of Alzheimer disease treatment drugs. The application of gypensapogenin A to the preparation of the Alzheimer disease treatment drugs is firstly publicized, the skeleton type is brand-new, the acetylcholinesterase suppression activity is unexpectedly strong and the possibility of giving any revelation by other compounds does not exist, so that prominent substantive features are provided anda remarkable progress in the prevention and treatment of the Alzheimer diseases is made at the same time. |
| priorityDate | 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.